Assessment of early‐death in gynecologic malignancy in the United States-Reference-Cited by-同舟云学术

Assessment of early‐death in gynecologic malignancy in the United States

Published:2024-09-02 Issue: Volume: Page:
ISSN:0020-7292
Container-title:International Journal of Gynecology & Obstetrics
language:en
Short-container-title:Intl J Gynecology & Obste

Author:

Vallejo Andrew¹,Lee Matthew W.¹,Klar Maximilian²,Wright Jason D.³,Matsuo Koji¹⁴⁵^ORCID

Affiliation:

1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology University of Southern California Los Angeles California USA

2. Department of Obstetrics and Gynecology University of Freiburg Faculty of Medicine Freiburg Germany

3. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology Columbia University College of Physicians and Surgeons New York City New York USA

4. Norris Comprehensive Cancer Center University of Southern California Los Angeles California USA

5. Department of Obstetrics and Gynecology Los Angeles General Medical Center Los Angeles California USA

Abstract

SynopsisPatients with gynecologic malignancy had overall lower early‐death rates following diagnosis compared with non‐gynecologic malignancies, with the exception of non‐Hispanic black patients with tubo‐ovarian cancer.

Publisher

Wiley

Link

https://obgyn.onlinelibrary.wiley.com/doi/pdf/10.1002/ijgo.15890

Reference5 articles.

1. Risk of early death in adolescents and young adults with cancer: a population-based study

2. Early death after a diagnosis of metastatic solid cancer–raising awareness and identifying risk factors from the SEER database

3. Racial and ethnic differences in early death among gynecologic malignancy

4. National Cancer Database.American College of Surgeons. Accessed June 26 2024.https://www.facs.org/quality‐programs/cancer‐programs/national‐cancer‐database/

5. Early Death After Chemotherapy as a Quality Indicator—Is It Time to Bench the Benchmark?